<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Market Newsdesk</provider_name><provider_url>https://www.marketnewsdesk.com</provider_url><author_name>Newsdesk</author_name><author_url>https://www.marketnewsdesk.com/index.php/author/newsdesk/</author_url><title>CytoSorbents Rights Offering Begins - Market Newsdesk</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="3w9sw1uQwc"&gt;&lt;a href="https://www.marketnewsdesk.com/index.php/cytosorbents-rights-offering-begins/"&gt;CytoSorbents Rights Offering Begins&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.marketnewsdesk.com/index.php/cytosorbents-rights-offering-begins/embed/#?secret=3w9sw1uQwc" width="600" height="338" title="&#x201C;CytoSorbents Rights Offering Begins&#x201D; &#x2014; Market Newsdesk" data-secret="3w9sw1uQwc" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.marketnewsdesk.com/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><description>To Participate, Eligible Stockholders Should Consult Their Broker or Financial Advisor in Advance of the Rights Offering Expiration on January 10, 2025 PRINCETON, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) &#x2014; CytoSorbents Corporation (NASDAQ: CTSO) announces the commencement of its Rights Offering, previously detailed in our December 9, 2024 announcement press release. Stockholders and certain Warrantholders of record on December 16, 2024 are now being distributed a dividend of one non-transferable Subscription Right Warrant (&#x201C;Subscription Right&#x201D;) for each share of common stock owned on the record date. Each Subscription Right, when exercised before the expiration date of 5:00PM EST on January 10, 2025, enables one Unit purchase at a subscription price of $1.00 per Unit. Each Unit consists of one share &hellip; Continue reading ""</description><thumbnail_url>https://www.globenewswire.com/newsroom/ti?nf=OTMyMzI4NSM2NjY5MTQwIzIwMjg2MTU=</thumbnail_url></oembed>
